Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | TET2 |
| Variant | mutant |
| Impact List | unknown |
| Protein Effect | unknown |
| Gene Variant Descriptions | TET2 mutant indicates an unspecified mutation in the TET2 gene. |
| Associated Drug Resistance | |
| Category Variants Paths |
TET2 mutant |
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT06630221 | Phase II | Eltrombopag | Eltrombopag As a Novel Therapeutic Approach for Low-risk MDS and CMML with TET2 Mutations | Recruiting | USA | 0 |
| NCT03397173 | Phase II | Azacitidine + Vitamin C | TET2 Mutations in Myelodysplastic Syndromes and Acute Myeloid Leukemia With Azacitidine + Ascorbic Acid | Completed | USA | 0 |